Bortesam 2mg Injection is a chemotherapy medication that belongs to the class of medicines called proteasome inhibitors. It consists of the active ingredient Bortezomib. It is indicated for the treatment of multiple myeloma and mantle cell lymphoma. Multiple myeloma refers to the cancerous progression of plasma cells that are predominant in the bone marrow. Mantle cell lymphoma is a less common cancer affecting the lymph nodes. This medication is concomitantly used with other chemotherapy medicines like pegylated liposomal doxorubicin, rituximab, cyclophosphamide, doxorubicin, dexamethasone, prednisolone or thalidomide for patients who have not started treatment and are ineligible for blood stem cell transplant. The common side effects likely associated with Bortesam 2mg Injection are Pneumonia, loss of appetite, sensitivity, tingling and burning sensation of the skin, nausea, vomiting, diarrhea, mouth ulcers, constipation, muscle and bone pain, hair loss, fever, infections, itching, redness, dehydration, stomach problems, etc., Inform your physician if these side effects disturb or persist in you.

Bortero 2mg Injection is a chemotherapy medication that belongs to the class of medicines called proteasome inhibitors. It consists of the active ingredient Bortezomib. It is indicated for the treatment of multiple myeloma and mantle cell lymphoma. Multiple myeloma refers to the cancerous progression of plasma cells that are predominant in the bone marrow. Mantle cell lymphoma is a less common cancer affecting the lymph nodes. This medication is concomitantly used with other chemotherapy medicines like pegylated liposomal doxorubicin, rituximab, cyclophosphamide, doxorubicin, dexamethasone, prednisolone or thalidomide for patients who have not started treatment and are ineligible for blood stem cell transplant. The common side effects likely associated with Bortero 2mg Injection are Pneumonia, loss of appetite, sensitivity, tingling and burning sensation of the skin, nausea, vomiting, diarrhea, mouth ulcers, constipation, muscle and bone pain, hair loss, fever, infections, itching, redness, dehydration, stomach problems, etc., Inform your physician if these side effects disturb or persist in you.

ZOMIB 2mg Injection is a chemotherapy medication that belongs to the class of medicines called proteasome inhibitors. It consists of the active ingredient Bortezomib. It is indicated for the treatment of multiple myeloma and mantle cell lymphoma. Multiple myeloma refers to the cancerous progression of plasma cells that are predominant in the bone marrow. Mantle cell lymphoma is a less common cancer affecting the lymph nodes. This medication is concomitantly used with other chemotherapy medicines like pegylated liposomal doxorubicin, rituximab, cyclophosphamide, doxorubicin, dexamethasone, prednisolone or thalidomide for patients who have not started treatment and are ineligible for blood stem cell transplant. The common side effects likely associated with ZOMIB 2mg Injection are Pneumonia, loss of appetite, sensitivity, tingling and burning sensation of the skin, nausea, vomiting, diarrhea, mouth ulcers, constipation, muscle and bone pain, hair loss, fever, infections, itching, redness, dehydration, stomach problems, etc., Inform your physician if these side effects disturb or persist in you.

Bortiva 2mg Injection is a chemotherapy medication that belongs to the class of medicines called proteasome inhibitors. It consists of the active ingredient Bortezomib. It is indicated for the treatment of multiple myeloma and mantle cell lymphoma. Multiple myeloma refers to the cancerous progression of plasma cells that are predominant in the bone marrow. Mantle cell lymphoma is a less common cancer affecting the lymph nodes. This medication is concomitantly used with other chemotherapy medicines like pegylated liposomal doxorubicin, rituximab, cyclophosphamide, doxorubicin, dexamethasone, prednisolone or thalidomide for patients who have not started treatment and are ineligible for blood stem cell transplant. The common side effects likely associated with Bortiva 2mg Injection are Pneumonia, loss of appetite, sensitivity, tingling and burning sensation of the skin, nausea, vomiting, diarrhea, mouth ulcers, constipation, muscle and bone pain, hair loss, fever, infections, itching, redness, dehydration, stomach problems, etc., Inform your physician if these side effects disturb or persist in you.

Research has shown that nutritional modifications can slow the progression of cardiac disease and improve quality of life of companion animals. Strongbeat is a unique formula that contains amino acids, vitamins, minerals and anti-oxidants that provide energy & strengthen heart muscle function in pets. Strongbeat can be used in dogs and cats with pre-existing suboptimal cardiovascular functions, in breeds that are predisposed to cardiovascular stress and to support the heart in geriatric or older patients.

Hyperphosphatemia or high phosphorus levels in the blood is one of the most common conditions during the progression of kidney disease in dogs and cats. Phosphate binders are medications used to reduce the absorption of dietary phosphate. Sevelamer carbonate is a calcium-free, aluminium-free, non-metal phosphate binder for dogs & cats. Phoslure treats hyperphosphatemia in patients with chronic kidney disease without the risk of hypercalcemia or aluminium toxicity. It significantly slows the progression of vascular calcification as compared to calcium-phosphate binders and reduces cardiovascular morbidity and mortality.

Oscinap is a combination of N-Acetyl Carnosine (NAC) & Sodium Carboxymethyl celulose (SCMC). Oscinap strengthens eye’s defence against free radicals and prrevents progression of cataracts in cats & dogs. N-Acetyl Carnosine penetrates the eye and gets further metabolized to form L-carnosine, an anti-glycating agent and oxidative stress reducer. When used with SCMC, NAC provides “sustained” action, SCMC is a eye lubricant and muco-adhesive provides temporary relief from burning and discomfort due to the eye’s dryness and acts as a protectant against further irritation.

Kidney disease is a silent killer in dogs & cats. In older population, as many as 10% of dogs and 35% cats have chronic kidney disease. Kynetra is a kidney health support formula that contains proven Chinese herbs and vitamins that help to maintain and support kidney function. has potential to slow down the progression of kidney disease. Kynetra contains scientifically proven Chinese herbs, Rehmannia glutinosa, Astragalus, Cordycepsus sinensis, is indicated for AKI – Acute Kidney Injury & Chronic CKD Conditions Slows down CKD Progression Supplementation is beneficial in CKD including nephropathy secondary to diabetes, and hypertension Helps in recovery from vitamin deficiency caused by CKD Has shown potential to decrease serum creatinine, increase creatine clearance Reduce proteinuria and alleviate CKD-associated complications Helps in preventing damage to nephrons from oxidative stress caused by CKD. Improves Kidneys function by reducing excretion of proteins. Acts as reno protective.

Aplazar Tablet is a nutritional supplement used in the treatment of chronic kidney disease. It reduces urea levels in the blood and helps prevent the progression of kidney disease. This way it delays the risk of undergoing long-term dialysis. Aplazar Tablet is to be taken by mouth with or without food. Take it in the exact dose and duration as advised by the doctor. Taking it along with a low-protein diet may help get the best of the medicine. Ensure that you maintain adequate calorie intake during treatment. While you are taking this medicine, your doctor may advise regular monitoring of serum calcium levels. This medicine is usually well tolerated with no common side effects. Ensure regular doctor consultation to evaluate medicine effects on your body. Before taking Aplazar Tablet, it is important to tell your doctor if you are taking any other medicines for other health conditions.